MPC Therapeutics Company
MPC Therapeutics is a biotechnology company. For patients with cancer and degenerative disorders, the company is presently concentrating on creating life-altering medications. They develop a class of compounds with the ability to modify mitochondrial processes in order to alter the conductivity of the cell and prevent the growth of diseases by using their medicinal chemistry and mitochondrial biology.
Founded Date:
2018-11-11
Employee Number:
1-10
Headquarters:
Plan-les-ouates, Geneve, Switzerland, Europe
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
Eclosion SA, FONGIT Innovation Fund, Innosuisse, KICK Ventures, Plutus Investment Group
Ipo Status:
private
City:
Plan-les-Ouates
Region:
Geneve
Country:
Switzerland
Founders:
Augustin de Bettignies, Benjamin Perry, Raphael Martinou